Skip to main content

Table 3 Immunization coverage in our study population aged 2-24 months

From: Determinants of vaccination coverage and adherence to the Greek national immunization program among infants aged 2-24 months at the beginning of the economic crisis (2009-2011)

Vaccine

n/N(%)

95% CI

DTaP-IPV-Hib

  

≥ 2 doses at 6 months

1.147/1.297 (88.4%)

86.7% - 90.2%

≥ 3 doses at 12 months

891/1.008 (88.4%)

86.4% - 90.4%

PCV

  

≥ 1 dose at 6 months

1.012/1.325 (77.1%)

74.8% - 79.3%

≥ 2 doses at 12 months

785/995 (78.9%)

76.4% - 81.4%

MCC

  

≥ 1 dose at 6 months

518/1.279 (40.5%)

37.8% - 43.2%

HepB

  

≥ 1 dose at 6 months

934/1.353 (69.0%)

66.6% - 71.5%

≥ 3 doses at 12 months

575/746 (77.1%)

74.1% - 80.1%

MMR*

287/356 (80.6%)

76.3% - 84.1%

Varicella*

308/352 (87.5%)

83.8% - 91.2%

Rotavirus (2 doses)

152/1.475 (10.3%)

8.8% - 11.9%

HAV (one dose at 24 months)

64/151 (42.4%)

34.5% - 50.3%

  1. *Since according to NIP MMR and varicella should be administered at 12-15 months, children ≥17 months were evaluated.
  2. DTaP = diphteria, tetanus and acellular pertussis vaccine.
  3. IPV = inactivated polio vaccine.
  4. Hib = conjugated haemophilus influenzae type B vaccine.
  5. MCC = meningococcal serotype C conjugated vaccine.
  6. HepB = hepatitis B vaccination.
  7. MMR = measles, mumps and rubella vaccine.
  8. HAV = hepatitis A vaccine.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us